glp-1 shortage news today 2025 glp 1 ending New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended FDA's GLP-1 decision kicks off

Later maladaptive hypertrophy often shows substrate inflexibility, mitochondrial dysfunction, oxidative stress, impaired calcium handling, and fibrosis

Hulst, M

The concentrate is mixed with water before consumption and is particularly suitable for integration into a training routine

Last Updated: Nov 18, 2025

clinical relevance in humans remains uncertain, but retatrutide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 [15] [16] Diabetic retinopathy a signal has been observed with rapid glycaemic improvement in the GLP-1 receptor agonist class